Cargando…
GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament
INTRODUCTION: Salvadora persica L. (S. persica, Siwak) has been used for many centuries as oral hygiene tools, particularly in Saudi Arabia. This study aimed to assess the effectiveness of S. persica petroleum ether extract (SPE) as an intracanal bactericidal for endodontic treatment against Enteroc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723863/ https://www.ncbi.nlm.nih.gov/pubmed/34987597 http://dx.doi.org/10.1155/2021/6333867 |
_version_ | 1784625812039794688 |
---|---|
author | Ayoub, Nahla Badr, Nadia Al-Ghamdi, Saeed S Alzahrani, Arwa Alsulaimani, Rahaf Nassar, Afnan Qadi, Rawabi Afifi, Ibtesam K. Swilam, Noha |
author_facet | Ayoub, Nahla Badr, Nadia Al-Ghamdi, Saeed S Alzahrani, Arwa Alsulaimani, Rahaf Nassar, Afnan Qadi, Rawabi Afifi, Ibtesam K. Swilam, Noha |
author_sort | Ayoub, Nahla |
collection | PubMed |
description | INTRODUCTION: Salvadora persica L. (S. persica, Siwak) has been used for many centuries as oral hygiene tools, particularly in Saudi Arabia. This study aimed to assess the effectiveness of S. persica petroleum ether extract (SPE) as an intracanal bactericidal for endodontic treatment against Enterococcus faecalis. Calcium hydroxide Ca(OH)(2) gold standard intracanal medicament was used for comparison. METHODS: The gas chromatography mass spectrometry (GC/MS) analysis was carried out to identify the components of SPE. First, the consistency of SPE was accomplished according to ANSI/ADA specification no 57. Forty-five single-rooted mandibular premolars were infected with that of E. faecalis suspension. Colony-forming units (CFU) were counted before the medicaments' application (CFU-1) and after seven days of their applications (CFU-2). Group I: SPE, Group II: positive control Ca(OH)(2), and Group III: saline solution negative control. The microdilution method was applied to determine minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of SPE. RESULTS: Thirty-two compounds were identified (89.09%), with main components of benzyl isothiocyanate (BITC) (33.32%) and steroids (34%). CFU before and after using SPE and Ca(OH)(2) recorded a statistically significant reduction in bacterial count (P=0.006) and (P=0.01), respectively. There was an insignificant difference between CFU after using SPE and Ca(OH)(2) (P=0.210). On the contrary, comparing both medicaments with the negative control saline group resulted in significant differences, (P=0.001) and (P=0.007), respectively. Moreover, the equality of minimum bactericidal concentration (MBC) and minimum inhibitory concentration (MIC) of SPE is recorded. CONCLUSION: This finding could be referred to the high content of bactericidal BITC in synergism with other antimicrobial components, representing 70.71% of SPE. Thus, SPE is a good candidate as an intracanal medicament, which warrants further investigation. |
format | Online Article Text |
id | pubmed-8723863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-87238632022-01-04 GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament Ayoub, Nahla Badr, Nadia Al-Ghamdi, Saeed S Alzahrani, Arwa Alsulaimani, Rahaf Nassar, Afnan Qadi, Rawabi Afifi, Ibtesam K. Swilam, Noha Evid Based Complement Alternat Med Research Article INTRODUCTION: Salvadora persica L. (S. persica, Siwak) has been used for many centuries as oral hygiene tools, particularly in Saudi Arabia. This study aimed to assess the effectiveness of S. persica petroleum ether extract (SPE) as an intracanal bactericidal for endodontic treatment against Enterococcus faecalis. Calcium hydroxide Ca(OH)(2) gold standard intracanal medicament was used for comparison. METHODS: The gas chromatography mass spectrometry (GC/MS) analysis was carried out to identify the components of SPE. First, the consistency of SPE was accomplished according to ANSI/ADA specification no 57. Forty-five single-rooted mandibular premolars were infected with that of E. faecalis suspension. Colony-forming units (CFU) were counted before the medicaments' application (CFU-1) and after seven days of their applications (CFU-2). Group I: SPE, Group II: positive control Ca(OH)(2), and Group III: saline solution negative control. The microdilution method was applied to determine minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of SPE. RESULTS: Thirty-two compounds were identified (89.09%), with main components of benzyl isothiocyanate (BITC) (33.32%) and steroids (34%). CFU before and after using SPE and Ca(OH)(2) recorded a statistically significant reduction in bacterial count (P=0.006) and (P=0.01), respectively. There was an insignificant difference between CFU after using SPE and Ca(OH)(2) (P=0.210). On the contrary, comparing both medicaments with the negative control saline group resulted in significant differences, (P=0.001) and (P=0.007), respectively. Moreover, the equality of minimum bactericidal concentration (MBC) and minimum inhibitory concentration (MIC) of SPE is recorded. CONCLUSION: This finding could be referred to the high content of bactericidal BITC in synergism with other antimicrobial components, representing 70.71% of SPE. Thus, SPE is a good candidate as an intracanal medicament, which warrants further investigation. Hindawi 2021-12-27 /pmc/articles/PMC8723863/ /pubmed/34987597 http://dx.doi.org/10.1155/2021/6333867 Text en Copyright © 2021 Nahla Ayoub et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ayoub, Nahla Badr, Nadia Al-Ghamdi, Saeed S Alzahrani, Arwa Alsulaimani, Rahaf Nassar, Afnan Qadi, Rawabi Afifi, Ibtesam K. Swilam, Noha GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament |
title | GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament |
title_full | GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament |
title_fullStr | GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament |
title_full_unstemmed | GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament |
title_short | GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament |
title_sort | gc/ms profiling and ex vivo antibacterial activity of salvadora persica (siwak) against enterococcus faecalis as intracanal medicament |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723863/ https://www.ncbi.nlm.nih.gov/pubmed/34987597 http://dx.doi.org/10.1155/2021/6333867 |
work_keys_str_mv | AT ayoubnahla gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament AT badrnadia gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament AT alghamdisaeeds gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament AT alzahraniarwa gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament AT alsulaimanirahaf gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament AT nassarafnan gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament AT qadirawabi gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament AT afifiibtesamk gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament AT swilamnoha gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament |